C Champions Oncology Inc
C
Uždarymo kaina
SektoriusSveikatos priežiūra
6.18
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
5.8100000000000005
Max
6.31
Pajamos | -514K -278K |
|---|---|
Pardavimai | 1.5M 17M |
P/E Sektoriaus vid. | 35.118 49.712 |
Pelnas, tenkantis vienai akcijai | -0.02 |
Pelno marža | -1.679 |
Darbuotojai | 213 |
EBITDA | -508K 104K |
Kitas uždarbis | 2026-07-22 |
|---|
Rinkos kapitalizacija | 5.1M 88M |
|---|---|
Ankstesnė atidarymo kaina | 6.18 |
Ankstesnė uždarymo kaina | 6.18 |
Naujienos nuotaikos
By Acuity
100%
0%
315 / 342 reitingas Healthcare
Champions Oncology Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.